Hoosier Cancer Research Network on Facebook
Login to Oncore Network
A Phase II Trial of Concurrent Chemoradiation With Consolidation Pembrolizumab (MK-3475) for the Treatment of Inoperable or Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC): HCRN LUN14-179
Status: Closed to Accrual Read More
Facebook
Hoosier Cancer Research Network on Facebook
Linked In
You Tube
Twitter